New Metabolites of Methyltrienolone by in Vitro Human Microsome and Characterized Using Liquid Chromatography/High Resolution Mass Spectrometry for Doping Control Purposes

Xiya Yan,Jinghua Hou,Siyu Yan,Wei Chang,Lisi Zhang,Zhanliang Wang,Sheng Yang
DOI: https://doi.org/10.1016/j.jpba.2024.116552
IF: 3.571
2024-01-01
Journal of Pharmaceutical and Biomedical Analysis
Abstract:Methyltrienolone (17(3-hydroxy-17 alpha-methylestra-4,9,11-trien-3-one) is one of the anabolic androgenic steroids (AAS) banned by the World Anti-Doping Agency (WADA). The biotransformation of methyltrienolone is performed in vitro by human hepatocytes microsomes. Both phase I and phase II experiments are investigated. The incubation samples were extracted and injected to Liquid Chromatography/High Resolution Mass Spectrometry (LC-HRMS), or reacted with methoxylamine (29 Da added) or hydroxylamine (15 Da added), to increase the detection sensitivity. The extracted ion chromatograms of the negative control and the positive samples are compared, and 7 groups of phase I metabolites were found. The metabolic pathways including 17-epimerization, mono-hydroxylation, dihydroxylation, reduced combining mono- or dihydroxylation, as well as 18-nor which are observed and tentatively identified according to the mass spectra by high resolution mass spectrometry. The 18nor metabolites will potentially be the long-term metabolite in doping control analysis. Its main phase II metabolites, glucuronides of metabolites are all obtained and analyzed.
What problem does this paper attempt to address?